Stem Cell Dysfunction in Aged Skeletal Muscle

老年骨骼肌干细胞功能障碍

基本信息

项目摘要

Abstract One of the greatest mysteries in ageing biology is to understand why many tissues and organs in our body, including skeletal muscle, decline in function as we get older? Recent studies suggest that the inability of muscle stem cells (MuSCs) to turn on the repair program after trauma is a major factor leading to the loss of muscle mass and strength observed in the elderly. However, given that the signals driving MuSCs into the regenerative state remains a mystery even in young adults, we are left with virtually no therapeutic options for boosting the repair potential of aging MuSCs in the clinic. To address this unmet need, my laboratory recently discovered a new “Super-Healing” adult stem cell activation program, driven by the transcription factor, FBJ osteosarcoma oncogene (FOS), that speeds up adult stem cell activation and enhances muscle repair. Intriguingly, a key downstream target gene of FOS in adult MuSCs is the NAD-consuming, cell surface enzyme, ADP-Ribosyl-Transferase 1 (Art1), which attaches an understudied post-translational modification (PTM), mono-ADP-Ribosylation (MARylation), to protein substrates. Excitingly, our preliminary data suggests that the FOS/ART1-MARylation pathway is disrupted in aged MuSCs, and thus, representing one of the earliest molecular alterations that diminish the regenerative potential of aged skeletal muscle. Thus, in this proposal, we will test the hypothesis that the FOS/AP-1 tissue regenerative program (including the ART1 pathway) is mis-regulated in aged skeletal muscle, triggering a cascade of molecular events that dampen stem cell activation potential and lead to the progressive deterioration of skeletal muscle with increasing age; and most importantly, that reversal of this molecular dysfunction will correct the stem cell activation and regenerative deficits seen in aged skeletal muscle. In Aim1, we will determine the expression patterns and functional significance of FOS/AP-1 gene targets in adult and aged MuSCs. In Aim2, we will determine the expression dynamics, functional requirements, and MARylated protein substrates of the newly discovered NAD/ART1-MARylation stem cell activation pathway in adult and aged MuSCs. Collectively, this work will highlight a new FOS/NAD/ART1-MARylation stem cell activation pathway that has been largely ignored in aging biology until now and whose further study will open new therapeutic avenues for improving muscle health in the elderly population.
摘要 衰老生物学中最大的谜团之一就是理解为什么我们身体中的许多组织和器官, 包括骨骼肌的功能会随着年龄的增长而下降最近的研究表明, 肌肉干细胞(MuSC)在创伤后开启修复程序是导致损伤的主要因素。 老年人的肌肉质量和力量。然而,考虑到驱动MuSC进入细胞的信号, 即使对于年轻人来说,再生状态仍然是一个谜,我们几乎没有任何治疗选择, 在临床上增强衰老MuSCs的修复潜力。为了满足这一未满足的需求,我的实验室最近 发现了一种新的“超级愈合”成人干细胞激活程序,由转录因子FBJ驱动 骨肉瘤癌基因(FOS),加速成人干细胞活化和增强肌肉修复。 有趣的是,FOS在成人MuSC中的关键下游靶基因是消耗NAD的细胞表面 酶,ADP-核糖基转移酶1(Art 1),其连接未充分研究的翻译后修饰 (PTM)单-ADP-核糖基化(MARylation)。令人兴奋的是,我们的初步数据表明 FOS/ART 1-MARylation途径在衰老的MuSC中被破坏,因此,代表了衰老的原因之一。 最早的分子改变,减少了老年骨骼肌的再生潜力。所以针对本 我们将测试FOS/AP-1组织再生计划(包括ART 1)的假设, 途径)在老年骨骼肌中被错误调节,引发了一系列分子事件, 细胞活化潜力,并导致骨骼肌随着年龄的增长而逐渐退化;以及 最重要的是,这种分子功能障碍的逆转将纠正干细胞活化, 在老年骨骼肌中观察到的再生缺陷。在目标1中,我们将确定表达模式, FOS/AP-1基因靶点在成年和老年MuSCs中的功能意义。在目标2中,我们将确定 表达动力学,功能要求,和MARylated蛋白质底物的新发现的 成人和老年MuSC中的NAD/ART 1-MAR化干细胞活化途径。总的来说,这项工作将 强调了一种新的FOS/NAD/ART 1-MARylation干细胞活化途径, 到目前为止,它的进一步研究将为改善肌肉开辟新的治疗途径 老年人的健康。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protocol for the isolation of mouse muscle stem cells using fluorescence-activated cell sorting.
  • DOI:
    10.1016/j.xpro.2023.102656
  • 发表时间:
    2023-12-15
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Elizalde, Gabriel;Munoz, Alma Zuniga;Almada, Albert E.
  • 通讯作者:
    Almada, Albert E.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Albert Ernesto Almada其他文献

Albert Ernesto Almada的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Control of genomic integrity and virulence of Aspergillus fumigatus by ADP-ribosylation.
通过 ADP-核糖基化控制烟曲霉的基因组完整性和毒力。
  • 批准号:
    MR/X007472/1
  • 财政年份:
    2023
  • 资助金额:
    $ 57.49万
  • 项目类别:
    Fellowship
Understanding the impact of DNA ADP-ribosylation on telomere function in cancer cells
了解 DNA ADP-核糖基化对癌细胞端粒功能的影响
  • 批准号:
    10751121
  • 财政年份:
    2023
  • 资助金额:
    $ 57.49万
  • 项目类别:
Composition and function of telomeric multi-protein complexes and their regulation by ADP-ribosylation
端粒多蛋白复合物的组成和功能及其ADP-核糖基化的调节
  • 批准号:
    2748032
  • 财政年份:
    2022
  • 资助金额:
    $ 57.49万
  • 项目类别:
    Studentship
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
  • 批准号:
    10524783
  • 财政年份:
    2022
  • 资助金额:
    $ 57.49万
  • 项目类别:
Regulation of DNA repair by histone ADP-ribosylation
组蛋白 ADP 核糖基化调节 DNA 修复
  • 批准号:
    MR/W017350/1
  • 财政年份:
    2022
  • 资助金额:
    $ 57.49万
  • 项目类别:
    Research Grant
Regulation and function of site-specific protein poly-ADP-ribosylation
位点特异性蛋白质聚 ADP 核糖基化的调控和功能
  • 批准号:
    10668492
  • 财政年份:
    2022
  • 资助金额:
    $ 57.49万
  • 项目类别:
ADP-ribosylation of DNA in Mycobacterium tuberculosis
结核分枝杆菌 DNA 的 ADP-核糖基化
  • 批准号:
    BB/W016613/1
  • 财政年份:
    2022
  • 资助金额:
    $ 57.49万
  • 项目类别:
    Research Grant
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
  • 批准号:
    10610165
  • 财政年份:
    2022
  • 资助金额:
    $ 57.49万
  • 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
  • 批准号:
    10389853
  • 财政年份:
    2021
  • 资助金额:
    $ 57.49万
  • 项目类别:
Role of Transcription Factor ADP-ribosylation in Breast Cancer Biology
转录因子 ADP-核糖基化在乳腺癌生物学中的作用
  • 批准号:
    10593900
  • 财政年份:
    2021
  • 资助金额:
    $ 57.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了